Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose GSK958108 for premature ejaculation
2008-005319-16Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in premature ejaculation (PE) comparing GSK958108 with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Nov 2008; status: completed.
02
Drugs
16448
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on 2008-005319-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005319-16.